Medicina, Italy

Alex Petrolati

This inventor holds 1 USPTO granted patent. Top assignee: Indena S.p.a.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alex Petrolati. Retrieved from https://idiyas.com/inventor/alex-petrolati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Alex Petrolati

Introduction

Alex Petrolati is a notable inventor based in Medicina, Italy. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on crystalline forms of lenvatinib. His research and inventions have the potential to impact the treatment of various medical conditions.

Latest Patents

Petrolati holds a patent for novel crystalline forms of 4-[3-Chloro-4-(N'-cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamide methanesulfonate. This invention provides new methods for the preparation of these crystalline forms, which could enhance the efficacy and stability of the drug.

Career Highlights

Throughout his career, Alex Petrolati has been associated with Indena S.p.a., a company known for its expertise in the development of plant-based active ingredients for the pharmaceutical industry. His work at Indena has allowed him to focus on innovative solutions that address complex challenges in drug formulation.

Collaborations

Petrolati has collaborated with esteemed colleagues such as Nicola Sardone and Stefano Luca Giaffreda. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.

Conclusion

Alex Petrolati's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic options and improved patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…